Summary
The process of designing and implementing clinical trials hasn’t changed much over the decades — which may be why 1 in 5 clinical trials fail due to insufficient patient enrollment, and fewer than 5 percent of adult patients take part in clinical trials at all.
Click below to read more at The Future of Personal Health.
View Publication
The True Cost of Ineffective Clinical Trials
Read more
You may also be interested in:
Blog
Good Clinical Practice: A PRA Perspective
Read Story
Blog
A Critical Success Factor in Rare Disease Clinical Research: Patient Advocacy Collaboration
In most public sectors, understanding the end user’s perspective and building out a product strategy around it is nothing short of dogma. However, in…
Read Story
Blog
Decoding FDA Gene Therapy Guidances Part Two: Rare Disease
In Part Two of Decoding FDA Gene Therapy Guidances, we discuss three separate guidances that provide further insight into how sponsors can safely and…
Read Story
View all related content and resources for Rare Disease
Explore Insights